RecruitingInterventionalNot ApplicableLast updated Nov 10, 2025

REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam

Reducing Exsanguination Via In-Vivo Expandable Foam

Overview

ClinicalTrials.gov ID: NCT02880163
Lead Sponsor: Arsenal Medical, Inc.INDUSTRY
Brief Summary: The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.
Study Type: Interventional

Status

Study Record Dates

NCT01838863Terminated

Control of Major Bleeding After Trauma Study

NCT02264730Unknown status

ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered

NCT01458561Terminated

Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery

NCT03366220Terminated

Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock

NCT01221389Withdrawn

Study Using Plasma for Patients Requiring Emergency Surgery

NCT01411852Completed

Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma